HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 99
HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HOLDKISS. The owner is based in HANGZHOU CITY, ZHEJIANG PROVINCE.
ROOM 1633, 16TH FLOOR, BUILDING 1, DINGCHUANG FORTUNE CENTER, CANGQIAN STREET, YUHANG DISTRICT
HANGZHOU CITY, ZHEJIANG PROVINCE , CN
Showing of trademarks Trademarks
Trademark Classifications
HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD. have?
HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD. file in?
HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD.'s most well-known trademarks?
HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as HOLDKISS. These are among 1 currently registered trademark in the portfolio.
What is HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD.'s trademark registration success rate?
HANGZHOU YUNFAN CROSS-TRADE TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.